Added to YB: 2026-05-26
Pitch date: 2026-03-19
IMR.AX [bullish]
Imricor Medical Systems, Inc.
Author Info
No bio for this author
Company Info
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East.
Market Cap
AUD 457.2M
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
-20.49
P/E
-15.78
EV/Sales
1.5K
Sector
Health Care Equipment and Supplies
Category
growth
Imricor Medical Systems, Inc. - $IMR.AX
IMR.AX: Only MRI-guided cardiac ablation platform replacing X-ray in $12-14bn market. 15yr IP moat (19 US, 71 foreign patents), no competitor. CE Mark granted, FDA PMA H2 2026. $3m/lab recurring rev at 71% margin. Base: 75 US+28 EU labs by FY31, $272m rev, 25% IRR. Bull: 125 US+46 EU labs, $453m rev, 58% IRR. Strategic acquirer targets: GE, Siemens, Philips, Medtronic, BSC, J&J. Risk: FDA delay 12-24mo
Read full article (47 min)